News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
202 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26981)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (202)
2 (163)
3 (150)
4 (1)
6 (113)
7 (192)
8 (195)
9 (146)
10 (94)
11 (1)
12 (5)
13 (183)
14 (272)
15 (209)
16 (183)
17 (86)
18 (3)
19 (5)
20 (142)
21 (207)
22 (173)
23 (165)
24 (67)
25 (3)
26 (3)
27 (139)
28 (227)
29 (177)
30 (210)
31 (85)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Drug Development
Flex Pharma Reports Second Quarter 2018 Financial Results
Flex Pharma, Inc. today announced its financial results for the three months ended June 30, 2018.
August 1, 2018
·
5 min read
Business
Platelet BioGenesis Moves to New Cambridge Lab Space to Support Continued Growth
Move to Nest.Bio Labs comes as company advances its program to commercialize a donor-independent source of lifesaving platelets
August 1, 2018
·
3 min read
Biotech Beach
Imprimis Announces Multi-Center Clinical Trial for Dropless® TriMoxi™ (Triamcinolone Acetonide-Moxifloxacin for injection) Formulation in Canada
Study to assess drug safety, patient preference and pharmacoeconomic measures in 200 routine cataract surgeries
August 1, 2018
·
6 min read
Business
Rigel Announces Conference Call and Webcast to Report Second Quarter 2018 Financial Results
Rigel Pharmaceuticals, Inc. announced that it will report its second quarter 2018 financial results after market close on Wednesday, August 8, 2018.
August 1, 2018
·
1 min read
Drug Development
Arrowhead Pharmaceuticals Earns $10 Million Milestone Payment from Amgen
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has earned a $10 million milestone payment from Amgen.
August 1, 2018
·
3 min read
BioMidwest
Exact Sciences Selects Vodori’s Pepper Flow to Support Commercialization of Cologuard
Pepper Flow supports Exact Sciences growth of sales and marketing materials while maintaining strict regulatory compliance
August 1, 2018
·
3 min read
Deals
Akumin Inc. Agrees to Acquire US$27.5 Million Revenue Business in Florida
This acquisition is expected to add approximately US$27.5 million of revenue based on the last twelve months of the period ended March 31, 2018
August 1, 2018
·
2 min read
Genetown
Torque Announces Proprietary Slipstream™ Platform for High-Efficiency Manufacturing of Deep-Primed T-Cell Therapies
UC Davis Good Manufacturing Practice facility to supply initial clinical trials using Slipstream manufacturing platform
August 1, 2018
·
5 min read
Job Trends
Heska to Present at Canaccord Genuity 38th Annual Growth Conference on August 8th
Heska Corporation announced that Kevin Wilson, Heska’s President & Chief Executive Officer will be presenting in a Fireside Chat at the Canaccord Genuity 38th Annual Growth Conference at 2:30 p.m. ET on Wednesday, August 8, 2018.
August 1, 2018
·
1 min read
FDA
FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo’s FLT3 Inhibitor Quizartinib for Relapsed/Refractory FLT3-ITD AML
Quizartinib has received FDA Breakthrough Therapy designation in patients with relapsed/refractory FLT3-ITD AML, a very aggressive form of the disease associated with poor prognosis
August 1, 2018
·
6 min read
Previous
8 of 21
Next